Report Identifies Schizophrenia Patients Likely To Receive Depot Medication
Main Category: SchizophreniaAlso Included In: Psychology / Psychiatry
Article Date: 28 Apr 2007 - 0:00 PDT
| Patient / Public: | ![]() |
5 (1 votes) |
| Healthcare Prof: | ![]() |
5 (1 votes) |
A report in the April 2007 issue of Psychiatric Services has identified a unique subgroup of schizophrenia patients in the United States who tend to receive depot antipsychotic medications.
The study, "Characteristics and Use Patterns of Patients Taking First-Generation Depot Antipsychotic or Oral Antipsychotic for Schizophrenia," led by Lizheng Shi, professor of health systems management at Tulane University School of Public Health and Tropical Medicine, examined data from a large randomized study on the treatment of 2,327 schizophrenia patients in the United States between July 1997 and Sept. 2003.
Patients with schizophrenia can improve with long-term treatment, but they may relapse if they do not follow antipsychotic medication regimens. Patient nonadherence to oral medication due to disorganization or disaffection with treatment has been difficult for clinicians to predict. Depot medications are administered by injection every two to four weeks, eliminating the need for daily oral dosing. Use of depot medication for patients in the identified subgroup may help reduce relapses among these patients, the study suggests. This unique group of patients is more likely to include African-Americans and persons who are less likely to be veterans, have had previous psychiatric hospitalizations, were more likely to have been arrested, use alcohol and illicit substances, and show psychotic symptoms and disorganized thinking.
Co-authors of the study are: Haya Ascher-Svanum, Baojin Zhu, Douglas Faries, and William Montgomery, Eli Lilly and Co.; Stephen R. Marder, West Los Angeles Veterans Affairs Medical Center, Los Angeles, Calif. and the School of Medicine of the University of California Los Angeles.
Tulane University
215 Gibson Hall
New Orleans, LA 70118-5698
United States
http://www2.tulane.edu/main.cfm
Visit our schizophrenia section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/69090.php>
APA
http://www.medicalnewstoday.com/releases/69090.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



